INTERNATIONAL PATENT: TERNS PHARMACEUTICALS, INC. FILES APPLICATION FOR "BCR-ABL1 INHIBITORS FOR USE IN TREATING CANCER"

GENEVA, Nov. 5 -- TERNS PHARMACEUTICALS, INC. (1065 E Hillsdale Blvd., Suite 100Foster City, California 94404) filed a patent application (PCT/US2025/025828) for "BCR-ABL1 INHIBITORS FOR USE IN TREATING CANCER" on Apr 22, 2025. With publication no. WO/2025/226724, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NELSON, Cara H. (c/o Terns Pharmaceuticals, Inc.1065 E Hillsdale Blvd., Suite 100Foster City, California 94404), ANDERSON, Kacey B. (c/o Terns Pharmaceuticals, Inc.1065 E Hillsdale Blvd., Suite 100Foster City, Cali...